BioCorRx (BICX) Cash from Operations (2016 - 2025)
BioCorRx (BICX) has disclosed Cash from Operations for 16 consecutive years, with 847722.0 as the latest value for Q4 2025.
- Quarterly Cash from Operations fell 242.97% to 847722.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2298291.0 through Dec 2025, down 109.65% year-over-year, with the annual reading at 2298291.0 for FY2025, 109.65% down from the prior year.
- Cash from Operations hit 847722.0 in Q4 2025 for BioCorRx, down from 634447.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 126499.0 in Q2 2025 to a low of 1338229.0 in Q2 2021.
- Historically, Cash from Operations has averaged 541362.9 across 5 years, with a median of 491706.0 in 2022.
- Biggest five-year swings in Cash from Operations: surged 73.72% in 2022 and later crashed 242.97% in 2025.
- Year by year, Cash from Operations stood at 647624.0 in 2021, then soared by 30.58% to 449576.0 in 2022, then decreased by 18.74% to 533836.0 in 2023, then soared by 53.7% to 247170.0 in 2024, then plummeted by 242.97% to 847722.0 in 2025.
- Business Quant data shows Cash from Operations for BICX at 847722.0 in Q4 2025, 634447.0 in Q3 2025, and 126499.0 in Q2 2025.